Rare lens disease Advocacy Hub | UniteRare

At a Glance

Live from database

No FDA or trial events recorded yet for Rare lens disease.

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Rare lens disease.
Check the disease page for updates →

1 FDA-approved

Xifaxan

(rifaximin)Orphan drugstandard

Salix Pharmaceuticals, Inc.

Rifamycin Antibacterial [EPC]

12.1 Mechanism of Action Rifaximin is an antibacterial drug [see Clinical Pharmacology ( 12.4 )].

No active clinical trials currently recruiting for Rare lens disease.
Search all trials →

No recent news articles indexed yet for Rare lens disease.
Search PubMed for Rare lens disease →

No specialists currently listed for Rare lens disease.

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants